Full House Resorts Announces Fourth Quarter Results
Mar 01, 2018 21:06 pm UTC| Business
- Net Revenues Decrease 1.0% in the Fourth Quarter Due to Weather Issues; For the Full Year, Net Revenues Increase 10.5% Due to a Full Year of Bronco Billy's and Increases in Every Operating Segment - Company Completes...
Victoria Muntean to Lead Kinsale’s Products Liability Division
Mar 01, 2018 21:06 pm UTC| Business
RICHMOND, Va., March 01, 2018 -- Kinsale Capital Group, Inc. (NASDAQ:KNSL) – Kinsale Insurance Company today announced Victoria Muntean’s promotion to Division Manager, Products Liability, effective March 1, 2018. ...
Global Self Storage Announces First Quarter 2018 Dividend
Mar 01, 2018 21:06 pm UTC| Business
NEW YORK, March 01, 2018 -- The board of directors of Global Self Storage, Inc. (NASDAQ:SELF), a real estate investment trust (REIT) that owns and operates self storage facilities, has declared a cash dividend of $0.065...
Net1’s affiliate Bank Frick now permits direct investments in leading crypto-currencies
Mar 01, 2018 21:06 pm UTC| Business
JOHANNESBURG, South Africa, March 01, 2018 -- Net 1 UEPS Technologies, Inc. (“Net1” or the “Company”) (NasdaqGS:UEPS); (JSE:NT1) today announced that its affiliate Bank Frick Co. AG (“Bank Frick”), a fully licensed...
Highwoods to Present at CITI 2018 Global Property CEO Conference
Mar 01, 2018 21:06 pm UTC| Business
RALEIGH, N.C., March 01, 2018 -- Highwoods Properties, Inc. (NYSE:HIW) announces Ed Fritsch, President and Chief Executive Officer, will participate in a Company roundtable presentation at the CITI 2018 Global Property...
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Mar 01, 2018 21:06 pm UTC| Business
BOSTON, March 01, 2018 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today...
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Mar 01, 2018 21:05 pm UTC| Business
NEWTON, Mass., March 01, 2018 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board of Directors granted stock...